Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

10812	Companies
234240	Keywords
163037	Articles
125255	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 10/23/2025 at 07:57, 9 months 15 days ago

Heidelberg Pharma’s Lead ADC Candidate HDP-101 Granted Fast Track Designation by US FDA for the Treatment of Multiple Myeloma
Heidelberg Pharma's lead ADC candidate HDP-101 granted Fast Track Designation by US FDA for the treatment of multiple myeloma. Accelerated review for innovative cancer therapy

Heidelberg Pharma Multiple Myeloma Fast Track Designation ADC Candidate US FDA
BRIEF

published on 10/09/2025 at 07:08, 9 months 29 days ago

Bilan de l'activité pharmaceutique Heidelberg pour les neuf premiers mois de 2025

Résultats Financiers Essais Cliniques Heidelberg Pharma HDP-101 Ajustement De La Stratégie
BRIEF

published on 10/09/2025 at 07:08, 9 months 29 days ago

Heidelberg Pharma's Nine-Month Update for 2025

Financial Results Clinical Trials Heidelberg Pharma HDP-101 Strategy Adjustment
PRESS RELEASE

published on 10/09/2025 at 07:03, 9 months 29 days ago

Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025
Heidelberg Pharma AG reports operational progress and financial figures for the first nine months of fiscal year 2025, focusing on lead ADC candidate HDP-101 and cost-saving measures

Financial Report Clinical Trial Cost-saving Measures Heidelberg Pharma AG ADC Candidate
BRIEF

published on 10/06/2025 at 16:03, 10 months 1 day ago

Heidelberg Pharma AG Revises Financial Guidance for 2025

Financial Guidance Heidelberg Pharma ADCs Operating Expenses Cash Requirements
BRIEF

published on 10/06/2025 at 16:03, 10 months 1 day ago

Heidelberg Pharma AG révise ses prévisions financières pour 2025

Heidelberg Pharma ADC Orientation Financière Dépenses D'exploitation Besoins De Trésorerie
PRESS RELEASE

published on 10/06/2025 at 15:58, 10 months 1 day ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its financial guidance for 2025, focusing on cost-saving measures. Sales, operating expenses, and cash requirements revised

Sales Financial Guidance Cost-saving Measures Heidelberg Pharma AG Operating Expenses
BRIEF

published on 09/25/2025 at 13:22, 10 months 12 days ago

Heidelberg Pharma fait progresser le HDP-101 dans un essai clinique pour le myélome multiple

HDP-101 Myélome Multiple Profil De Sécurité Essai De Phase I/IIa Activité Clinique
BRIEF

published on 09/25/2025 at 13:22, 10 months 12 days ago

Heidelberg Pharma Advances HDP-101 in Clinical Trial for Multiple Myeloma

HDP-101 Multiple Myeloma Safety Profile Phase I/IIa Trial Clinical Activity
PRESS RELEASE

published on 09/25/2025 at 13:17, 10 months 12 days ago

Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma
Heidelberg Pharma advances to Cohort 9 in Phase I/IIa trial of lead ATAC candidate HDP-101 in multiple myeloma, demonstrating favorable safety profile and early signs of clinical activity

Heidelberg Pharma Multiple Myeloma ATAC Candidate Phase I/IIa Trial Clinical Activity

Accesswire

Published on 08/08/2026 at 00:00, 4 hours 39 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 5 hours 24 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 5 hours 39 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 6 hours 9 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 6 hours 24 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 23:21, 5 hours 18 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 9 hours 9 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 9 hours 24 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 10 hours 29 minutes ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 10 hours 39 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026

Les Echos

Published on 08/07/2026 at 18:54, 9 hours 45 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 9 hours 45 minutes ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 9 hours 58 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 9 hours 58 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 10 hours 39 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE